10222 BARNES CANYON ROAD, BLDG. #2, SAN DIEGO, CA
Crinetics Pharmaceuticals Announces Merger Agreement and Stock Options Vesting
News
Other Events
Reports Second Quarter 2026 Financial Results and Provides Business Update
Material disclosure
Vertex to Acquire Pharmaceuticals
Election of Three Class II Directors at Crinetics Pharmaceuticals
Q2
Q1
FY 2024
Q3
Notice of Suspension of Duty to File Reports
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Merger Proxy Statement
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notification Filed by a National Security Exchange
S-8 POS
Automatic Shelf Registration Statement